Virginia Retirement System’s Jazz Pharmaceuticals JAZZ Stock Holding History

Virginia Retirement System’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$15.6M	Buy	+119,497	New	+$14.9M	0.23%	140

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Virginia Retirement System's JAZZ Position: Q1 2016 in Review

Virginia Retirement System opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2016: 119,497 shares worth $15.6M. The stake represents 0.23% of the portfolio and ranks #140 among its holdings.

339 funds tracked by Wall St. Rank hold JAZZ as of Q1 2016.

Virginia Retirement System held 119,497 shares of Jazz Pharmaceuticals worth $15.6M as of Q1 2016.
Jazz Pharmaceuticals was a new Virginia Retirement System position in Q1 2016.
Jazz Pharmaceuticals made up 0.23% of Virginia Retirement System's portfolio in Q1 2016, its #140 holding.
339 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2016.

Based on Virginia Retirement System's 13F filing for Q1 2016, filed 29 Apr 2016.